These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30156150)

  • 1. Effects of Bioactive Peptide on Inflammatory Bowel Disease, Focus on Signal Transduction and Intestinal Microbiota.
    Ma Y; Yan W; Ding S; Fei Y; Liu G; Fang J
    Curr Pharm Des; 2018; 24(24):2782-2788. PubMed ID: 30156150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease.
    Ghattamaneni NKR; Panchal SK; Brown L
    Pharmacol Res; 2018 Jun; 132():99-107. PubMed ID: 29680446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease.
    Fernández-Tomé S; Marin AC; Ortega Moreno L; Baldan-Martin M; Mora-Gutiérrez I; Lanas-Gimeno A; Moreno-Monteagudo JA; Santander C; Sánchez B; Chaparro M; Gisbert JP; Bernardo D
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31683517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.
    Ihara S; Hirata Y; Koike K
    J Gastroenterol; 2017 Jul; 52(7):777-787. PubMed ID: 28534191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
    Leber A; Hontecillas R; Tubau-Juni N; Zoccoli-Rodriguez V; Abedi V; Bassaganya-Riera J
    Front Immunol; 2018; 9():363. PubMed ID: 29535731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
    Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
    Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease.
    Zhao L; Zhang S; He P
    Curr Pharm Des; 2017; 23(34):5173-5179. PubMed ID: 29032748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease.
    Melhem H; Kaya B; Ayata CK; Hruz P; Niess JH
    Cells; 2019 May; 8(5):. PubMed ID: 31091682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Pediatric Inflammatory Bowel Disease.
    Peloquin JM; Goel G; Villablanca EJ; Xavier RJ
    Annu Rev Immunol; 2016 May; 34():31-64. PubMed ID: 27168239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol and inflammatory bowel disease: the evidence so far.
    Nunes S; Danesi F; Del Rio D; Silva P
    Nutr Res Rev; 2018 Jun; 31(1):85-97. PubMed ID: 29191255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome and chronic inflammatory bowel diseases.
    Wehkamp J; Frick JS
    J Mol Med (Berl); 2017 Jan; 95(1):21-28. PubMed ID: 27988792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut biofilm forming bacteria in inflammatory bowel disease.
    Srivastava A; Gupta J; Kumar S; Kumar A
    Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation.
    de Medina FS; Daddaoua A; Requena P; Capitán-Cañadas F; Zarzuelo A; Dolores Suárez M; Martínez-Augustin O
    Proc Nutr Soc; 2010 Aug; 69(3):454-62. PubMed ID: 20598199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.
    Cario E
    World J Gastroenterol; 2017 Mar; 23(9):1513-1520. PubMed ID: 28321153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Signal Pathway of Antibiotic Alternatives on Intestinal Microbiota and Immune Function.
    Wang J; Han M; Zhang G; Qiao S; Li D; Ma X
    Curr Protein Pept Sci; 2016; 17(8):785-796. PubMed ID: 27226197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic signaling during intestinal inflammation.
    Longhi MS; Moss A; Jiang ZG; Robson SC
    J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.